Phase 1 Study of YZJ-5053 Tablets in Advanced Solid Tumors Initiated
A Phase 1 clinical trial is underway to assess the safety and efficacy of YZJ-5053 tablets in patients with advanced solid tumors.
Asset / Drug
Drug and asset intelligence for YZJ-5053 with 2 indexed intelligence signals across regulatory, clinical, competitive, and market developments.
No catalysts indexed for this entity yet.
No related entities indexed yet.
Newsletter
Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.
No paywall. No spam. Unsubscribe anytime.